Use of donors with genitourinary malignancies for liver transplantation: a calculated risk?

Transpl Int. 2017 Jul;30(7):737-739. doi: 10.1111/tri.12962. Epub 2017 May 22.

Authors

Affiliations

¹ Hepatobiliary Surgery and Liver Transplantation Unit, University of Pisa Medical School Hospital, Pisa, Italy.
² Hepatobiliary Surgery and Liver Transplantation Unit, Sapienza University of Rome, Rome, Italy.
³ Division of Urology, IRCCS San Matteo Hospital, Pavia, Italy.

PMID: 28390074
DOI: 10.1111/tri.12962

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Renal Cell / diagnosis
Female
Humans
Incidental Findings
Kidney Neoplasms / diagnosis
Liver Transplantation / adverse effects
Liver Transplantation / methods*
Male
Prostatic Neoplasms / diagnosis
Risk Factors
Tissue Donors*
Tissue and Organ Procurement
Urogenital Neoplasms / diagnosis*